Tumor-tropic E. coli engineered as living T and NK cell engagers
Year: 2026
Type: preprint
Authors: Shaobo Yang, Anna Clara Bader, Stephanie Sendker, Ashley Hu, Daniel Chuyang Chen, Hetal Nath, Alice Chen, Eden Bobilev, Michal Sheffer, Veronica W. Hui, Tereza E. Kochs, Andreia Maia, Jiting Tang, Fuguo Liu, Xingyu Deng, Maily Nguyen, Mila Stanojevic, Mubin Tarannum, Castilleja L. Albert, Alaa Kassim Ali, Roman Shapiro, Yun Wei, Ke Zhang, Zongqi Wang, Young Rock Chung, Erin Parry, Marco Campisi, David Barbie, Andrew A. Lane, Hongyu Li, Keith L. Ligon, Kun Huang, Kai W. Wucherpfennig, Seema Chugh, Evelyn Ullrich, Hermann Einsele, Jianzhu Chen, John Koreth, Vanessa S. Silveira, Robert Soiffer, Jessica S. Little, Catherine J. Wu, Jerome Ritz, Jiahe Li, Andrew J. Aguirre, Rizwan Romee
Institutions: Harvard University, Parker Institute for Cancer Immunotherapy, Dana-Farber Cancer Institute, University of Würzburg, Northeastern University, University of Michigan, Dana-Farber/Harvard Cancer Center, Goethe University Frankfurt, Universitätsklinikum Würzburg, Koch Institute for Integrative Cancer Research At MIT, Massachusetts Institute of Technology, Brigham and Women's Hospital
Subfield: Biotechnology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7203830918